Clinical Trial Update: Tolvaptan for Advanced or Refractory Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of tolvaptan for advanced or refractory heart failure has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hyponatremia

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: University of Calgary | Conditions: Heart Failure, Hyponatremia | Phase 4 | Status: TERMINATED